-
Locked Data M_2_13_b
Number of individuals starting a new opioid prescribing episode with extended-release or long-acting opioid formulation -
Locked Data M_2_12_2
Number of opioid-related emergency department visits with MOUD follow-up within 31 days (Medicaid) -
Locked Data M_2_14_1
Number of naloxone units distributed through community-based programs -
Locked Data M_2_15_1
Number of individuals with OUD who are screened for hepatitis C -
Locked Data M_2_15_2
Number of individuals with OUD who are diagnosed with hepatitis C -
Locked Data M_2_15_3
Number of individuals with OUD who are treated for hepatitis C -
Locked Data M_2_16
Number of newly diagnosed HIV cases -
Locked Data Population values for HCS data analysis
There is no description for this dataset
-
Locked Data M_2_12_1
Number of individuals linked to MOUD following opioid-related emergency department visit (Medicaid) -
Locked Data M_2_13_a
Number of individuals with a new opioid prescribing episode with a duration of more than 30 days -
Locked Data M_2_13
Number of individuals with a new high-risk opioid prescribing episode (outcome measure for HCS Hypothesis 4) -
Locked Data M_1
Number of opioid overdose deaths (outcome measure for HCS Hypothesis 1) -
Locked Data M_1_5
Number of opioid overdose deaths involving any opioid and any psychostimulant (including cocaine) -
Locked Data M_2_1
Number of drug overdose deaths -
Locked Data M_1_6
Number of opioid overdose deaths involving any opioid and any benzodiazepine -
Locked Data M_3_5_1_b
There is no description for this dataset
-
Locked Data M_3_5_1_a
There is no description for this dataset
-
Locked Data M_3_5_1_c
There is no description for this dataset
-
Locked Data M_1_3
Number of opioid overdose deaths involving any opioid and any psychostimulant (excluding cocaine) -
Locked Data M_1_2
Number of opioid overdose deaths involving synthetic opioids other than methadone (fentanyl)